Research Nester recently published report titled “Global Voiding Cystourethrogram Market: Global Demand Analysis & Opportunity Outlook 2027” delivers detailed overview of the global Voiding Cystourethrogram market in terms of market segmentation by product type, by age, by end use and by regions."
The global voiding cystourethrogram market is segmented by Product Type into Voiding Cystourethrogram (VCUG) and Fluoroscopic or Radionuclide Cystogram (RNC); by age adult Voiding Cystourethrogram and pediatric Voiding Cystourethrogram; by end use hospitals, specialty clinics and radiology centers and by regions. According to American Urological Association, there are 150 million people effected by UTIs around the world latest by Feb, 2019 and U.S itself is experiencing 1 million UTIs every year which is expected to escalate the CAGR at a high rate for voiding cystourethrogram market during the forecast period i.e. 2018-2027.
The market of voiding cystourethrogram is expected to grow on the back of rising healthcare awareness coupled with disposable income. High prevalence of urinary diseases in children along with growing imaging centers across the developed and developing regions around the globe are expected to bolster the high growth of voiding cystourethrogram during the forecast period.
North America is expected to dominate the market growth at a high rate during the forecast period owing to high healthcare research investments and prevalence of better medical facilities initiated by government of U.S. in this region. Additionally, Asia Pacific is anticipated to be the fastest growing market during the forecast period on the account of numerous investments in medical research and developments as well as rising centers diagnosing urinary diseases in the developing countries such as China and India. Additionally, the European healthcare sector is expected to grow at a high pace owing to its enhanced healthcare infrastructure which in turn is anticipated to escalate the demand for Voiding Cystourethrogram in the market of this region.
Steady Rise in Urinary Infections
Voiding Cystourethrogram are used in diagnosis of urinary infections and other disorders related to bladder, urethra, uterus and kidney. The growing population coupled with rising disposable income has encouraged the market growth of Voiding Cystourethrogram. The prevalence of urinary infections in children are very high and with growing consumer awareness, regular checkups and diagnosis has uplifted the standard of healthcare at personal level.
However, the high cost of tests are unaffordable by rural people in many regions of developing countries which is expected to create a hindrance to the market growth further over the forecast period.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model. This report also provides the existing competitive scenario of some of the key players of the global Voiding Cystourethrogram market which includes company profiling of Merck & Co., Inc., Koninklijke Philips N.V., General Electric Company, Block Imaging International, Inc., Carestream Health, Inc., Siemens AG, BMI Biomedical International s.r.l., Hitachi Medical Systems, Medtronic and FUJIFILM Holdings Corporation. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global Voiding Cystourethrogram market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.